Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
about
Molecular cloning and phylogenetic analysis of human immunodeficiency virus type 1 subtype C: a set of 23 full-length clones from BotswanaFunctional properties and epitope characteristics of T-cells recognizing natural HIV-1 variantsIdentification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine designComprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 allelesMagnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C.Human immunodeficiency virus type 1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?Human immunodeficiency virus vaccinesSafety and Immunogenicity of the MRKAd5 gag HIV Type 1 Vaccine in a Worldwide Phase 1 Study of Healthy AdultsHIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor.Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development.Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load.Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1Patient-specific cytotoxic T-lymphocyte cross-recognition of naturally occurring variants of a human immunodeficiency virus type 1 (HIV-1) p24gag epitope by HIV-1-infected children.
P2860
Q33648343-E90DCE01-CCF0-403C-AD1E-DA64E86B467DQ33753695-276587DF-D1E7-4DC6-8E07-B2DB2E676092Q33845527-AD6F36FF-DB3A-4958-91C0-B7728E0B2466Q34339044-03AE8FA5-6BBE-4219-AD4A-B940DBEF17EBQ34348269-0BD5AAB9-8BCF-4CB8-91B2-0BCE69563EAEQ34364357-E01EE459-5B3F-4AC3-B939-43C77EF1A0A6Q35674731-F2FF7F7B-88D1-4122-9B6E-6D8D43128877Q36172965-D5FBFCA8-2C46-4B26-8C85-A9567C21BBF0Q36399832-2B1302D3-0F27-4BF7-9D60-445E15393E19Q36600351-CCE143BC-480F-47BC-BF5E-B447FB36F67EQ37009811-F37F8B67-8496-47A3-9D18-43DEF87E10B3Q37568289-54079BCD-5381-45D2-B7EC-DB7F53E57D0FQ39602888-90A48670-814E-4C18-9A42-4C1BC8221005
P2860
Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Cross-clade envelope glycoprot ...... HIV type 1 clade B infection.
@ast
Cross-clade envelope glycoprot ...... HIV type 1 clade B infection.
@en
type
label
Cross-clade envelope glycoprot ...... HIV type 1 clade B infection.
@ast
Cross-clade envelope glycoprot ...... HIV type 1 clade B infection.
@en
prefLabel
Cross-clade envelope glycoprot ...... HIV type 1 clade B infection.
@ast
Cross-clade envelope glycoprot ...... HIV type 1 clade B infection.
@en
P2093
P356
P1476
Cross-clade envelope glycoprot ...... HIV type 1 clade B infection.
@en
P2093
Mazzara GP
Pedersen SL
Sheppard HW
Tartaglia J
Wilkins VL
P304
P356
10.1089/AID.1998.14.925
P577
1998-07-01T00:00:00Z